Maternal Immunization Efficacy and Safety Saad B. Omer
|
|
- Georgiana Tucker
- 6 years ago
- Views:
Transcription
1 Maternal Immunization Efficacy and Safety Saad B. Omer William H. Foege Professor of Global Health Professor of Epidemiology & Pediatrics Emory University, Schools of Public Health & Medicine
2 Pregnancy Pre-partum Birth 6 wks (2 mo) After Birth 10 wks (4 mo) 14 wks (6 mo) Some infections more dangerous in pregnancy (e.g. influenza, Hepatitis E) 5 3 mil. deaths (0-27 days) Mortality data: Liu et al., Lancet; 2012
3 3 Omer, New Eng. J. Med., 2017
4 4 Influenza
5 Pregnancy & infancy as risk factors for severe disease attributable to seasonal influenza Odds ratios for a cardiopulmonary event during influenza season among pregnant women aged years (referent group: postpartum women) Bhat N et al. N Engl J Med Dec 15;353(24): Neuzil KM, Reed GW, Mitchel EF, et al.. Am J Epidemiol.. 5
6 63% reduction in infant influenza after maternal vaccination in pregnancy Shehzad Noorani 17 Zaman et al., New Eng Journal of Medicine, 2008
7 Distribution of the Number of Weeks of Exclusive Breastfeeding 18 Omer, et al., New Eng Journal of Medicine, 2009
8 Synergy between Influenza Virus & S. pneumoniae (pneumococcus) Influenza infection predisposes to pneumococcus Altered immune system particularly innate immune system Most deaths in the 1918 influenza pandemic due to secondary pneumococcal infection 20
9 One-two punch of maternal influenza immunization + infant pneumococcal conjugate vaccine
10 % Efficacy Efficacy of PCV +TIV for Respiratory Illness with Fever Full Study Period Flu Circulation Period Mother PPSV23; Infant Hib Mother PPSV23; Infant PCV7 Mother Control Mother Control Infant Control Infant PCV Mother TIV Infant Control Mother TIV; Infant Hib Mother TIV Infant PCV Mother TIV; Infant PCV7 TIV: Trivalent (inactivated) influenza vaccine; PCV7: 7-valent pneumococcal conjugate vaccine 10 Omer et al., J. Infect. Dis., 2013
11 WHO Strategic Advisory Group of Experts (SAGE) Recommendation: Countries considering the initiation or expansion of seasonal influenza vaccination programmes give the highest priority to pregnant women 24 Wkly Epidemiol Rec., 2012
12 Three Bill & Melinda Gates Foundation Trials Mali Nepal South Africa 25 UN Photo/John Isaac UNFPA/Anna Adhikari UN Photo/P Mugabane
13 Vaccine Efficacy against laboratory confirmed influenza in infants -Data from RCTs 14 Omer, New Eng. J. Med., 2017
14 Vaccine Efficacy against laboratory confirmed influenza in mothers -Data from RCTs 15 Omer, New Eng. J. Med., 2017
15 Birth weight (g) Baseline Mean Birth weight in Trial Countries Nepal 1 Mali 2 South Africa 3 Bangladesh 4 1) Mullany et al., 2007; 2) Teguete et al., 2012; 3) Sabet et al., 2009; 4) UNICEF
16 17 Steinhoff M, IDSA, 2015; Tapia M et al., The Lancet,,2016; Madhi S et al., NEJM, 2014; Steinhoff M et al., Canadian Medical Association Journal, 2012.
17 Steinhoff et al., CMAJ, Distribution of birth weight by vaccine group and circulation period - Bangladesh Mother's Gift Trial
18 Location specific nuances Nepal was the only trial to have low birth weight as a (co-)primary outcome Gestational age at vaccination was lower for the Nepal trial compared to other 3 trials Baseline birth weight was lower in the populations where the Nepal trial was conducted compared to other study sites 32
19 Maternal Influenza Vaccine Evidence of impact on lab confirmed infant influenza Emerging evidence for impact on severe outcomes in infants Appreciating location specific nuances Seasonality Baseline rates of outcomes of interest Evidence-based decision-making
20 22 Pertussis Vaccine
21 Pertussis Burden WHO estimate: 16 million cases/year 95% in developing countries Infants too young to be completely vaccinated at high-risk More severe disease in young infants compared to older children & adults Combined tetanus, diphtheria, and (acellular) pertussis (Tdap) vaccine recommended for pregnant women in multiple countries. (without a phase III clinical trial) 39 WHO, 2011: CDC, 2012
22 40 Kharbanda et al. JAMA. 2014
23 Time Since Prior Tetanus-Containing Vaccine & RR of Tdap Safety Outcomes 2.97 Local Reactions 3.00 Small for Gestational Age 3.00 Preterm Delivery <2 years 2-5 years 0.33 <2 years 2-5 years 0.33 <2 years 2-5 years Reference group: >5 years since prior tetanus-containing vaccine 25 Sukumaran et al., JAMA, 2015
24 26 GBS Vaccine
25 Invasive GBS disease in infants Early-onset GBS (EOGBS) occurs before age 7 days sepsis without a focus (80%-95%) pneumonia (10%-15%) meningitis (5%-10%) Late-onset GBS (LOGBS) occurs in infants aged 7 to 89 days old Meningitis more frequent (21% 35%)» 30% of cases have permanent sequelae (eg, hearing loss, developmental delay). 27 Healy & Baker in Vaccines, 6th Ed.
26 Epidemiology of Group B Streptococcal infection in pregnant women (United States) Universal screening No change in lateonset disease in infants or disease in pregnancy 43 Phares et al. JAMA May 7;299(17):
27 Invasive Group B Streptococcal Infection in Pregnant Women Pregnancy Outcomes Among Women with Invasive GBS Active, population-based surveillance in 10 U.S. states Identified 409 invasive GBS infections in pregnant women 61% 4% 5% SAB or Stillbirth Infant Clinical Infetion Induced Abortion 29 Phares et al. JAMA May 7;299(17):
28 Proportions of Cases of Bacterial Meningitis Caused by Each Pathogen U.S. Emerging Infections Program Thigpen, et al. NEJM, 2011
29 Potential mechanisms of maternal GBS colonization leading to adverse pregnancy outcomes Supportive data Maternal GBS colonization Preliminary data Intra-amniotic, urinary tract, or systemic GBS infection Bacterial virulence factors Subclinical local or systemic inflammation Preterm birth 47
30 Association between Group B Streptococcal colonization and preterm delivery Cross-Sectional Case Control Pooled Cross-Sectional + Case Control Cohort Studies Valkenburg-van den Berg et al. Acta Obstet Gynecol Scand. 2009;88(9):958-67
31 GBS Vaccine Progress Trivalent Type Ia, Ib and III Vaccine to Prevent GBS Infection (Novartis) Purified CPS conjugated to CRM197 Phase I & II trials Further clinical development plans evolving 33
32 34 RSV Vaccine
33 55 Hall et al. NEJM, 2009
34 36 Hall et al. NEJM, 2009
35 Global Neonatal and Infant Deaths in Lozano R et al. Lancet, 2012
36 Estimated case fatality ratio in children <5 years admitted to hospital for RSV-associated severe ALRI <1 year <5 years Industrialised countries 0 7% ( ) 0 3% ( ) Developing countries 2 1% ( ) 2 1% ( ) 38 Nair et al. Lancet, 2010
37 39
38 40
39 41 Ethics
40 legitimacy of a mother s interests in the welfare of her fetus/infant 43
41 Characteristics of an Interests-based Approach Mother s agency front and center Inclusion of women in decision-making Limits options for mandatory maternal immunization Chamberlain et al., Science, 2017
42 Thank 45
(ACIP) 2018:28:69-76 DOI: /ICJ _28(2) (07)
69 1 2 1 2 (ACIP) B 2018:28:69-76 E 106 1 15 107 3 14 123 (07) 7317123 DOI: 10.6526/ICJ.201804_28(2).0003 107 4 70 [1] (Tdap) B E (estradiol) T (type 2 helper T-cell, Th2) T (type 1 helper T-cell, Th1)
More informationMaternal Influenza Immunization at WHO
Maternal Influenza Immunization at WHO Dr. Justin R. Ortiz Medical Officer Initiative for Vaccine Research GAP Partners Meeting Dubai, UAE 26 March 2014 WHO Position Paper Mother s Gift Trial GAVI Review
More informationShabir A. Madhi. Global Overview of Maternal Immunisation
Shabir A. Madhi Global Overview of Maternal Immunisation National Institute for Communicable Diseases & University of Witwatersrand, South Africa Respiratory and Meningeal Pathogens Research Unit, & DST/NRF:
More informationData and Approaches in National and International Immunization Studies. Emory University, Schools of Public Health & Medicine & CHRSE
Data and Approaches in National and International Immunization Studies Saad B. Omer, MBBS MPH PhD Emory University, Schools of Public Health & Medicine & CHRSE Outline Characteristics of vaccine refusers
More informationShabir A. Madhi. Progress and Challenges of Immunization Contributing Toward Attaining the MDG Goal to Reduce under-5 Childhood Mortality.
Shabir A. Madhi Progress and Challenges of Immunization Contributing Toward Attaining the MDG Goal to Reduce under-5 Childhood Mortality. National Institute for Communicable Diseases & University of Witwatersrand,
More informationI have no disclosures
Immunizations in Pregnancy: a critical element of care Laura E. Riley, M.D. Associate Professor of Obstetrics and Gynecology Harvard Medical School Division of Maternal Fetal Medicine Massachusetts General
More informationShabir A. Madhi Possibilities for reducing neonatal and young infant mortality through Maternal immunization
Shabir A. Madhi Possibilities for reducing neonatal and young infant mortality through Maternal immunization National Institute for Communicable Diseases & University of Witwatersrand, South Africa Respiratory
More informationAfter participating in the conference, you should have improved your knowledge of, and enhanced your competence to:
Vaccine Preventable Diseases Shouldn t Happen in Pregnancy: Immunizations for Mother and Baby Laura E. Riley, M.D. Associate Professor of Obstetrics and Gynecology Harvard Medical School Division of Maternal
More informationMaternal immunization: current status and future directions
Maternal immunization: current status and future directions Vaccinology 2017 III International Symposium for Asia Pacific Experts Hanoi, Vietnam October 17, 2017 Deshayne Fell, PhD Assistant Professor,
More informationMaternal Immunization: Unique considerations of public health value of vaccines given to pregnant women
Maternal Immunization: Unique considerations of public health value of vaccines given to pregnant women Estimating the full public health value of vaccines Kathleen M. Neuzil, MD, MPH Professor of Medicine
More informationMaternal influenza immunisation
Maternal influenza immunisation Cheryl Cohen Centre Head Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases cherylc@nicd.ac.za Global causes of death in children
More informationMaternal Immunization Promises and Challenges
Maternal Immunization Promises and Challenges Flor M. Munoz, MD Associate Professor of Pediatrics Section Infectious Diseases Molecular Virology and Microbiology Houston, Texas Overview Rationale and concept
More informationPrevention of Infections in Mothers & Infants
Helen Y. Chu, MD MPH Division of Allergy & Infectious Diseases University of Washington Prevention of Infections in Mothers & Infants June 2, 2015 Midwives Association of Washington State Conference Financial
More informationInfluenza immunization in pregnancy: observations in mother, fetus, infant
Influenza immunization in pregnancy: observations in mother, fetus, infant Mark C. Steinhoff, MD Director, Global Health Center Professor of Pediatrics Cincinnati Children s Hospital Medical Center Cincinnati
More informationIMMUNIZATION IN PREGNANCY
IMMUNIZATION IN PREGNANCY Dr. Chelsea Elwood, B.M.ScH, M.Sc, MD,FRCSC Reproductive Infectious Diseases Fellow Department of Obstetrics and Gynecology University of British Columbia cnelwood@cw.bc.ca Disclosure
More informationVaccines including Tdap in pregnancy
Vaccines including Tdap in pregnancy Dr. Manish Sadarangani Director, Vaccine Evaluation Center, BC Children s Hospital Research Institute Assistant Professor, Division of Infectious Diseases, Department
More informationVaccinating to Protect Mother and Child Mark H. Yudin, MD, MSc, FRCSC
Vaccinating to Protect Mother and Child Mark H. Yudin, MD, MSc, FRCSC Department of Obstetrics & Gynecology St. Michael s Hospital Associate Professor, University of Toronto Chair, Infectious Diseases
More informationDeveloping a novel Group B Streptococcus (GBS) Vaccine. Patrick Tippoo
Developing a novel Group B Streptococcus (GBS) Vaccine Patrick Tippoo Presentation 1. Overview of Biovac 2. GBS Project Overview 3. African Significance Biovac Overview A Centre of Excellence rooted in
More informationOverview of Maternal Immunization: Benefitting Mothers and Their Infants
Overview of Maternal Immunization: Benefitting Mothers and Their Infants Janet A. Englund, M.D. Seattle Children s Hospital University of Washington Fred Hutchinson Cancer Research Center Seattle, WA USA
More informationUpdate on influenza maternal immunization. Joachim Hombach WHO Initiative for Vaccine Research
Update on influenza maternal immunization Joachim Hombach WHO Initiative for Vaccine Research Influenza Burden of Disease WHO global estimate: 3-5 million severe cases, 250 000 500 000 deaths
More informationAPEC Guidelines Immunizations
Pregnancy provides an excellent opportunity to enhance a woman s protection against disease and to provide protection to the neonate during the first 3 to 6 months of life. Women of childbearing age should
More information21 st Century Vaccine Challenges
21 st Century Vaccine Challenges Presentation by Rosalyn Singleton MD, ANTHC Slides adapted from original powerpoint by: Carrie L. Byington, MD HA and Edna Benning Presidential Professor of Pediatrics
More informationHealthy People 2020 objectives were released in 2010, with a 10-year horizon to achieve the goals by 2020.
Appendix 1: Healthy People 2020 Immunization-related Objectives Healthy People provides science-based, 10-year national objectives for improving the health of all Americans. For three decades, Healthy
More informationMATERNAL VACCINATION. Dr Sushena Krishnaswamy
MATERNAL VACCINATION Dr Sushena Krishnaswamy CVU November 2017 Outline 1. Principles 2. Flu- infant benefit 3. Pertussis- optimal timing, cocooning 4. How we re faring 5. Strategies to improve uptake 6.
More informationMonitoring results: goals, strategic objectives and indicators
page 108 Monitoring results: goals, strategic objectives and indicators 6. SURVEILLANCE Strategic Objective 4: strong immunization sytems are an integral part of a well-functioning health system. Indicator
More informationJeanne S. Sheffield, MD Professor, Maternal-Fetal Medicine University of Texas Southwestern Medical Center
Jeanne S. Sheffield, MD Professor, Maternal-Fetal Medicine University of Texas Southwestern Medical Center About 800 women died every day in 2010 due to complications of pregnancy and child birth, including
More informationMaternal Immunizations: Protects Mothers, Fetuses and Newborn Infants
Maternal Immunizations: Protects Mothers, Fetuses and Newborn Infants Michael T. Brady, MD Professor of Pediatrics The Ohio State University Associate Medical Director Nationwide Children s Hospital Maternal
More informationInfluenza in the pediatric population
Influenza in the pediatric population Annual attack rates 10%-40% in children Hospitalization Increased risk in children
More informationShabir A Madhi Director: National Institute for Communicable Disease & Medical Research Council: Respiratory and Meningeal Pathogens Research Unit
Shabir A Madhi Director: National Institute for Communicable Disease & Medical Research Council: Respiratory and Meningeal Pathogens Research Unit » 45% (2.7 million) of under-5 deaths occurred in first
More informationPertussis: Trends, Prevention and Challenges Flor M. Munoz, MD Associate Professor Pediatric Infectious Diseases
Pertussis: Trends, Prevention and Challenges Flor M. Munoz, MD Associate Professor Pediatric Infectious Diseases Disclosure I do not have any relevant conflicts of interest to disclose. Page 1 xxx00.#####.ppt
More informationUPDATE ON IMMUNIZATION GUIDELINES AND PRACTICES
DISCLOSURES UPDATE ON IMMUNIZATION GUIDELINES AND PRACTICES Nothing to disclose Kylie Mueller, Pharm.D., BCPS Clinical Specialist, Infectious Diseases Spartanburg Regional Medical Center LEARNING OBJECTIVES
More informationPotential public health impact of RSV vaccines. R. Karron December 2016
Potential public health impact of RSV vaccines R. Karron December 2016 1. RSV is The leading cause of hospitalization in infants and in many high-income countries; >2 million medical visits annually in
More informationACIP Meeting Update, New Recommendations and Pending Influenza Season
ACIP Meeting Update, New Recommendations and Pending Influenza Season February 17 th 2011 www.immunizetexas.com ACIP Upcoming Agenda and New Recommendations ACIP (February 23-24 th 2011) Topics for meeting
More informationPneumococcal vaccines
Pneumococcal vaccines Marco Aurélio Sáfadi, MD, PhD FCM da Santa Casa de São Paulo Challenges in establishing the baseline burden of disease, before implementing a vaccination program S. pneumoniae disease
More informationThe National Immunisation Schedule Update and Current issues. Dr Brenda Corcoran National Immunisation Office.
The National Immunisation Schedule Update and Current issues Dr Brenda Corcoran National Immunisation Office : Dates vaccines introduced into the Irish immunisation schedule Vaccine 1937-1999 Date introduced
More information2017 Vaccine Preventable Disease Summary
2017 Vaccine Preventable Disease Summary Prepared 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata October 2018 2017 Summary of Vaccine Preventable Diseases in Ottawa County This is a detailed
More informationUpdate on Adult Immunization
Update on Adult Immunization Paul J. Carson, MD, FACP Sanford Health, Infectious Disease NDSU Master of Public Health Program UND School of Medicine and Health Sciences When meditating over a disease,
More informationPneumococcal vaccines. Safety & Efficacy. Prof. Rajesh Kumar, MD PGIMER School of Public Health Chandigarh
Pneumococcal vaccines Safety & Efficacy Prof. Rajesh Kumar, MD PGIMER School of Public Health Chandigarh Disclosure Slide X X I DO NOT have any significant or other financial relationships with industry
More informationMatching enhances IIS data assessing Tdap and influenza vaccine uptake during pregnancy in Washington State
Matching enhances IIS data assessing Tdap and influenza vaccine uptake during pregnancy in Washington State Joanna Eavey, MSPH - joanna.eavey@doh.wa.gov AIRA IIS National Meeting April 5 7, 2016 Background
More informationS. Michael Marcy Memorial Lecture
S. Michael Marcy Memorial Lecture Lessons Learned from Making Vaccine Recommendations Larry K. Pickering, MD, FAAP April 16, 2016 Los Angeles, CA FINANCIAL DISCLOSURE: Larry K. Pickering, M.D., F.A.A.P.
More informationInfluenza Backgrounder
Influenza Backgrounder Influenza Overview Influenza causes an average of 36,000 deaths and 200,000 hospitalizations in the U.S. every year. 1,2 Combined with pneumonia, influenza is the seventh leading
More information3 rd dose. 3 rd or 4 th dose, see footnote 5. see footnote 13. for certain high-risk groups
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years 2013. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations must be read
More informationGuidelines for Vaccinating Pregnant Women
Guidelines for Vaccinating Pregnant Women March 2012 Guidelines for Vaccinating Pregnant Women Abstracted from recommendations of the Advisory Committee on Immunization Practices (ACIP) MARCH 2012 Risk
More informationOutline. Why Adult Immunization Matters. Recommended Adult Vaccines: Age Based. Why Do We Vaccinate? Footnotes. Risk Based
Why Adult Immunization Matters Outline CDC Recommended Adult Vaccines Burden of U.S. adult vaccine preventable disease Vaccine effectiveness in adults Adult immunization coverage rates Ramifications of
More informationGroup B Streptococcus
Group B Streptococcus (Invasive Disease) Infants Younger than 90 Days Old DISEASE REPORTABLE WITHIN 24 HOURS OF DIAGNOSIS Per N.J.A.C. 8:57, healthcare providers and administrators shall report by mail
More informationEssential Vaccinations for HIV-Positive Adults and Adolescents
Essential Vaccinations for HIV-Positive Adults and Adolescents Janak A. Patel, MD Professor & Director, Pediatric Infectious Diseases Director, Maternal-Child Program University of Texas Medical Branch
More informationDeaths/yr Efficacy Use Prev Deaths/yr. Influenza 36,000 70% 60% 18,000. Pneumonia 40,000 60% 40% 20,000 HBV 6,000 90% 30% 4,000
Tetanus, Diptheria, Pertussis,! Measles, Mumps, Rubella, Varicella, HPV, Polio Meningococcus, Pneumococcus,! Influenza, Hepatitis B, Hepatitis A,! H influenza, Rabies, Typhoid,! Yellow Fever, Japanese
More information2016 Vaccine Preventable Disease Summary
2016 Vaccine Preventable Disease Summary 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata Prepared October 2017 2016 Summary of Vaccine Preventable Diseases (VPDs) Reported to Ottawa County
More informationVaccines on the Global Scale
Vaccines on the Global Scale Learning from the past and aiming at the future Edwin J. Asturias, MD Associate Professor of Pediatrics and Epidemiology Director for Latin America Center for Global Health,
More informationWelcome to the CIC Education Hour
Welcome to the CIC Education Hour Protecting Mothers and Infants Through Maternal Immunizations Objectives Describe the rationale for maternal immunization Outline current US maternal immunization recommendations
More informationNew Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines
New Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines Antigens Vaccine Approved Age Daptacel Diphtheria, Tetanus, and acellular Pertussis (DTaP)
More informationWHO INFLUENZA VACCINE RECOMMENDATION
WHO INFLUENZA VACCINE RECOMMENDATION Strategic Advisory Group of Experts (SAGE) on Immunization SAGE Working Group on Influenza Vaccine and Immunization 1 Evidence Evaluation: Conceptual Matrix Target
More informationJournal Club 3/4/2011
Journal Club 3/4/2011 Maternal HIV Infection and Antibody Responses Against Vaccine-Preventable Diseases in Uninfected Infants JAMA. 2011 Feb 9;305(6):576-84. Jones et al Dept of Pediatrics, Imperial College,
More informationIn Case of Technical Difficulties
Maternal Immunization: Protecting Mother and Baby Thursday, August 10, 2017 12:00 PM ET In Case of Technical Difficulties If you hear an echo: Make sure you are only logged in once on your computer Select
More informationClinical Infectious Diseases MAJOR ARTICLE
Clinical Infectious Diseases MAJOR ARTICLE Impact of Timing of Influenza Vaccination in Pregnancy on Transplacental Antibody Transfer, Influenza Incidence, and Birth Outcomes: A Randomized Trial in Rural
More informationAppendix An Assessment Tool to Determine the Validity of Vaccine Doses
Appendix 4.4 - An Assessment Tool to Determine the Validity of Vaccine Doses Note: Refer to the Canadian Immunization Guide and New Brunswick (NB) immunization program directives for recommendations for
More informationImmunization Update: New CDC Recommendations. Blaise L. Congeni M.D. 2012
Immunization Update: New CDC Recommendations Blaise L. Congeni M.D. 2012 Polysaccharide Vaccines Vaccine Hib capsule polysaccharide PRP (polyribose ribitol phosphate) Not protective in infants
More information301 W. Alder, Missoula, MT or
301 W. Alder, Missoula, MT 59802 406-258-4745 or 406-258-3363 Routine Immunizations are available on a walk-in basis: Mondays, Tuesdays, Thursdays, and Fridays from 9:00am to 4:30pm Wednesdays, 10:00am-4:30pm
More informationGlobal and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office.
Global and National Trends in Vaccine Preventable Diseases Dr Brenda Corcoran National Immunisation Office Global mortality 2008 Children under 5 years of age 1.5 million deaths due to vaccine preventable
More information2013 Adult Immunization Update. David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle
2013 Adult Immunization Update David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle Adult Immunization Update Pertussis Vaccine Influenza Vaccine Zoster
More informationPNEUMONIA : PROMISE FULFILLED? Regina Berba MD FPSMID
PNEUMONIA : PROMISE FULFILLED? Regina Berba MD FPSMID Objectives of Lecture Know the quality of current evidence based guidelines on immunization Appreciate the performance of pneumonia vaccines in terns
More informationI mun u i n s i atio i n o n u p u d p a d te
Immunisation update Brian Eley Paediatric Infectious Diseases Unit Red Cross War Memorial Children s Hospital Department of Paediatrics and Child Health University of Cape Town Immunisation schedules,
More informationGuidelines for Vaccinating Pregnant Women
Guidelines for Vaccinating Pregnant Women April 2013 Guidelines for Vaccinating Pregnant Women Abstracted from recommendations of the Advisory Committee on Immunization Practices (ACIP) April 2013 Risk
More informationNOTE: The above recommendations must be read along with the footnotes of this schedule.
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years 2013. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations must be read
More informationProtecting Two: Maternal Immunization Opportunities & Challenges
Protecting Two: Maternal Immunization Opportunities & Challenges R A C H E L H E R L I H Y, M D, M P H D I R E C T O R D I V I S I O N O F D I S E A S E C O N T R O L & E N V I R O N M E N T A L E P I
More information11/9/2012. Group B Streptococcal Infections: Consensus and Controversies. Prevention of Early-Onset GBS Disease in the USA.
Group B Streptococcal Infections: Consensus and Controversies Carol J. Baker, M.D. Professor of Pediatrics, Molecular Virology and Microbiology Executive Director, Center for Vaccine Awareness and Research
More informationObjectives. Immunity. Diphtheria. Immunization Update July 22, Individual Immunity
Immunization Update July 22, 2008 Presented by Robert Brayden, MD Associate Professor, UCHSC Child Health Clinic, The Children s s Hospital Hosted by: Community Health Association of Mountain/Plains States
More informationAdjustment to rating 2 RCTs and post-hoc analysis 1, 2, 3, 4, 5 4. Serious 6-1. Inconsistency None serious 0. None serious 0.
1 Table 6. Safety of inactivated influenza vaccine in pregnant women Is seasonal inactivated influenza vaccine versus non- influenza vaccine in pregnant women safe in regard to health outcomes for the
More informationImmunizations are among the most cost effective and widely used public health interventions.
Focused Issue of This Month Recommended by the Korean Pediatric Society, 2008 Hoan Jong Lee, MD Department of Pediatrics, Seoul National University College of Medicine E mail : hoanlee@snu.ac.kr J Korean
More information4/7/13. Vaccinations for Adults and Adolescents. Effect of Full Use of Adult Immunizations. General Vaccine Information
Vaccinations for Adults and Adolescents Nicholas A. Daniels, MD MPH Department of Medicine Professor of Clinical Medicine Declaration of full disclosure: No conflict of interest 2 Effect of Full Use of
More informationPregnancy and Shots! Shots! Shots! An Update. Kelli D Barbour, MD 4 December 2015
Pregnancy and Shots! Shots! Shots! An Update Kelli D Barbour, MD 4 December 2015 Objectives Review recommended adult vaccinations and pregnancy Review recommended immunizations in pregnancy and the puerperium
More informationProtecting Infants and Children from Pertussis and Influenza
September 23, 2016 Paulomi Shah, DO, FAAP Pediatrician, Medical Director Children s Medical Services, Sonoma County Alan Shotkin, MD, FAAP Neonatologist, Medical Director Santa Rosa Memorial Hospital Protecting
More informationPneumococcal pneumonia
Pneumococcal pneumonia Wei Shen Lim Consultant Respiratory Physician & Honorary Professor of Medicine Nottingham University Hospitals NHS Trust University of Nottingham Declarations of interest Unrestricted
More informationWHY WE RE HERE. Melinda Wharton, MD, MPH Director, Immunization Services Division. National Center for Immunization & Respiratory Diseases
National Center for Immunization & Respiratory Diseases WHY WE RE HERE Melinda Wharton, MD, MPH Director, Immunization Services Division AIM Leadership Conference February 8, 2017 Vaccines save lives.
More informationHaemophilus influenzae
Haemophilus influenzae type b Severe bacterial infection, particularly among infants During late 19th century believed to cause influenza Immunology and microbiology clarified in 1930s Haemophilus influenzae
More informationA Randomized Controlled Trial of an Educational Intervention to Promote Influenza Vaccine Uptake Among Pregnant Women
A Randomized Controlled Trial of an Educational Intervention to Promote Influenza Vaccine Uptake Among Pregnant Women Valerie W. Y. Wong RN MPH Daniel Y. T. Fong PhD Marie Tarrant RN MPH PhD School of
More informationOVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE
OVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE Dr Tiong Wei Wei, MD, MPH Senior Assistant Director Policy and Control Branch, Communicable Diseases Division Ministry of Health 9
More informationHIV Infection in Pregnancy. Francis J. Ndowa WHO RHR/STI
HIV Infection in Pregnancy Francis J. Ndowa WHO RHR/STI FJN_STI_2005 Department of reproductive health and research Département santé et recherche génésiques Session outline Effect of pregnancy on HIV
More informationPreventive care guidelines for children and adults.
Preventive care guidelines for children and adults. Keeping a focus on regular preventive care can help you and your family stay healthy. Preventive care can help you avoid potentially serious health conditions
More informationPneumococcal vaccination in UK: an update. Dr Richard Pebody Immunisation Department Health Protection Agency Centre for Infections
Pneumococcal vaccination in UK: an update Dr Richard Pebody Immunisation Department Health Protection Agency Centre for Infections Leading infectious causes of mortality, 2000 WHO estimates 3.5 Deaths
More informationIMMUNIZATIONS IN WOMEN 2014
IMMUNIZATIONS IN WOMEN 2014 Carol E. Hayes, CNM, MN, MPH American College of Nurse Midwives representative to CDC Advisory Committee on Immunization Practice (ACIP) Myths Vs Facts See Talking Point document
More informationNOTE: The above recommendations must be read along with the footnotes of this schedule.
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years United States, 2014. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations
More informationACIP Recommendation Update. Mark H. Sawyer, MD UCSD School of Medicine Rady Children s Hospital San Diego
ACIP Recommendation Update Mark H. Sawyer, MD UCSD School of Medicine Rady Children s Hospital San Diego What has ACIP been up to lately? New Recommendations Tdap vaccination for each pregnancy Meningococcal
More informationAndrew Kroger, MD, MPH National Center for Immunization and Respiratory Diseases MCH & Immunization Conference Anchorage, AK September 28, 2010
2010 Immunization Update Andrew Kroger, MD, MPH National Center for Immunization and Respiratory Diseases MCH & Immunization Conference Anchorage, AK September 28, 2010 Disclosures No financial conflict
More informationDisclosure Statement. Encapsulated Bacteria. Functions of the Spleen 10/25/2017. Pharmacist Learning Objectives
Pharmacist Learning Objectives No Spleen? No Problem. A Review of Vaccinations Indicated for the Asplenic Patient SCSHP Fall Meeting October 26, 2017 Explain the rationale for vaccinations in Select the
More informationPertussis in California: The changing landscape of prevention and control
Pertussis in California: The changing landscape of prevention and control Kathleen Winter, PhD, MPH Rebeca Boyte, MAS Immunization Branch California Department of Public Health Pertussis (whooping cough)
More informationUpdate on Vaccine Recommendations. Objectives. Childhood Immunization Schedule At the Turn of the Century. New Horizons in Pediatrics April 30, 2017
Centers for for Disease Disease Control Control and and Prevention Prevention National Center for Immunization and Respiratory Diseases Update on Vaccine Recommendations New Horizons in Pediatrics April
More informationSession 1 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER
Session 1 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER Disclosure The Immunization Action Coalition has been responsible for all aspects of content development for the enclosed presentation
More informationF.A.S.N. annual conference 2009 Alix Casler, M.D., F.A.A.P. Orlando, FL
F.A.S.N. annual conference 2009 Alix Casler, M.D., F.A.A.P. Orlando, FL Immunization Update for School Nurses Overview of Vaccine Preventable Diseases FL Vaccine Requirements Medical Guidelines vs State
More informationThese slides are the property of the presenter. Do not duplicate without express written consent.
Cancer Survivorship Protecting Against Vaccine Preventable Diseases Heidi Loynes BSN, RN Immunization Nurse Educator Michigan Department of health and Human Services (MDHHS) loynesh@michigan.gov Are Vaccine-Preventable
More informationImpact and effectiveness of national immunisation programmes. David Green, Nurse Consultant, Immunisations Public Health England
Impact and effectiveness of national immunisation programmes David Green, Nurse Consultant, Immunisations Public Health England Session objectives Immunisation planning and implementation The impact and
More informationProtecting the Innocent Bystander The Importance of Vaccination During Pregnancy
Disclosures Protecting the Innocent Bystander The Importance of Vaccination During Pregnancy Judy Guzman-Cottrill, DO Professor of Pediatrics Division of Infectious Diseases Oregon Health & Science University
More informationPublic Statement: Medical Policy. Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many. Document: ARB0454:04.
ARBenefits Approval: 01/01/2012 Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many Medical Policy Title: Immunization Coverage Document: ARB0454:04 Administered by: Public Statement: 1.
More informationSamir K Saha, Ph.D Child Health Research Foundation Dhaka Shishu Hospital Dhaka, Bangladesh
Barriers Rotavirus to Rotavirus Vaccine Impact Vaccine Beyond Preventing Introduction Diarrhea Samir K Saha, Ph.D Child Health Research Foundation Dhaka Shishu Hospital Dhaka, Bangladesh 13 th International
More information2/20/2019. The need for adult vaccinations. Update on Adult Immunizations. The Need for Adult Vaccinations. Objectives:
The need for adult vaccinations Update on Adult Immunizations Objectives: Recall the latest recommendations on adult vaccinations Detail the importance of adult vaccinations I m not a kid.. Why are you
More informationAdvancing RSV maternal immunization: A gap analysis brief An analysis to identify needs for vaccine decision-making and introduction
Advancing RSV maternal immunization: A gap analysis brief An analysis to identify needs for vaccine decision-making and introduction Despite significant advances in child survival, deaths in the earliest
More informationNeil S. Silverman, MD Center for Fetal Medicine & Women s Ultrasound, LA Clinical Professor, Dept. of Obstetrics and Gynecology Division of
Neil S. Silverman, MD Center for Fetal Medicine & Women s Ultrasound, LA Clinical Professor, Dept. of Obstetrics and Gynecology Division of Maternal-Fetal Medicine David Geffen School of Medicine at UCLA
More informationAdult Immunization. Allison McGeer, MSc, MD, FRCPC Sinai Health System, University of Toronto
Adult Immunization Allison McGeer, MSc, MD, FRCPC Sinai Health System, University of Toronto CFPC COI Templates: Slide 1 DISCLOSURE OF FINANCIAL SUPPORT and CONFLICT OF INTEREST This lecture has received
More informationGuidelines Description USPSTF HRSA CDC Benefit Description Types Ages
Guidelines Description USPSTF Evidence-based items or services that have a rating of A or B in the current recommendations of the United States Preventive Services Task Force HRSA Evidence-informed exams,
More information